Lazard downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley downgraded Lazard (LAZ) to Underweight from Equal Weight with a price target of $33, down from $56. Recent trade developments raise recession risk and the firm expects the M&A pipeline to be impacted by deteriorating market conditions and prolonged uncertainty for CEOs looking to do deals, the analyst tells investors.